{"anticipatedPostingDate":"2029-05","denomUnitsSelected":"Participants","description":"Outcome data will be provided after the study is completed.","reportingStatus":"NOT_POSTED","timeFrame":"Days 1 and 8 of Cycle 1, Day 1 of Cycle 3 and Day 8 after Intra-participant Dose Escalation (each cycle is 28 days)","title":"Area Under the Concentration-Time Curve From 0 to 24 Hours (AUC0-24) of LOXO-292","type":"SECONDARY"}